MarketAxess Holdings Inc. MKTX

MarketAxess Holdings Inc. se dedica a operar plataformas electrónicas para la negociación de valores de renta fija y proporcionar datos relacionados, análisis, herramientas de cumplimiento y servicios post-negociación. Ofrece un mercado de negociación abierto que ofrece soluciones de negociación de todos con todos en los mercados de crédito globales, creando un grupo de liquidez para una variedad de participantes en el mercado de crédito. Está involucrado en el uso de una amplia gama de protocolos de negociación, incluidas solicitudes de cotización, libros de órdenes en vivo, negociación basada en sesiones y soluciones de negociación de carteras, así como sus recursos de datos y análisis. Ofrece ofertas de datos integradas y accionables, incluidos Composite+ y Axess All, precios en tiempo real para ayudar a los clientes con decisiones de negociación y análisis de costos de transacción. La empresa ofrece una variedad de servicios post-negociación, incluido el procesamiento directo, el emparejamiento de operaciones, la publicación de operaciones, la presentación de informes regulatorios de transacciones y datos de mercado y referencia en productos de renta fija y otros.

Con 6 acciones de MKTX (USD 984,34) habrías recibido USD 18,60 en dividendos en los últimos 12 meses.

• GlobeNewswire Inc. 3 sept

  BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

  Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).

  

• Zacks Investment Research 3 sept

  Here's Why Investors Should Stay Neutral on MarketAxess Stock for Now

  MarketAxess (MKTX) is diversifying beyond U.S. credit with international expansion and new trading protocols, with non-U.S. credit revenues rising 9%. However, U.S. credit revenues declined 9%, and the stock carries an elevated forward P/E of 19.08X above industry average. The company maintains strong financials and consistent earnings beats, but faces risks from trading volume sensitivity and investment costs, warranting a neutral stance.

  

• GlobeNewswire Inc. 6 ago

  MKTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of MarketAxess to Intercontinental Exchange

  Law firm Wohl & Fruchter is investigating whether the proposed sale of MarketAxess to Intercontinental Exchange at $167.00 per share is fair to shareholders, given the stock's 52-week high of $200.90 and a recent UBS price target of $200.00. Shareholders have expressed concerns that the deal undervalues the company.

  

• GlobeNewswire Inc. 5 ago

  Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether insiders are receiving substantial benefits unavailable to ordinary shareholders and whether transaction terms limit competing offers. The investigations cover Forte Biosciences' sale to argenx, Luxfer Holdings' sale to Wynnchurch Capital affiliates, Sanara MedTech's sale to MiMedx Group, and MarketAxess Holdings' sale to Intercontinental Exchange.

  

• GlobeNewswire Inc. 4 ago

  Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.